Northwire Canada EditionFriday, October 16, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4196.30 +0.6% SILVER 57.93 +1.4% COPPER 6.63 +1.1% OIL 96.16 −1.9% PALLADIUM 1125.75 −0.2% NPR 0.620 −1.6% QZM 0.380 −2.6% BVA 0.760 −3.8% ONAU 0.520 −1.9% FMR 0.225 +0.0% GSVR 0.340 +3.0% PHNM 0.340 −1.4% SLG 5.71 +0.5% CASA 0.060 +0.0% DRY 0.215 −6.5% SOMA 0.560 +1.8% PWRO 0.025 +0.0% OMI 0.250 +2.0% EMR 0.100 −4.8% PDN 7.10 −1.2% FDY 4.79 +0.4% GOLD 4196.30 +0.6% SILVER 57.93 +1.4% COPPER 6.63 +1.1% OIL 96.16 −1.9% PALLADIUM 1125.75 −0.2% NPR 0.620 −1.6% QZM 0.380 −2.6% BVA 0.760 −3.8% ONAU 0.520 −1.9% FMR 0.225 +0.0% GSVR 0.340 +3.0% PHNM 0.340 −1.4% SLG 5.71 +0.5% CASA 0.060 +0.0% DRY 0.215 −6.5% SOMA 0.560 +1.8% PWRO 0.025 +0.0% OMI 0.250 +2.0% EMR 0.100 −4.8% PDN 7.10 −1.2% FDY 4.79 +0.4%
Regulatory

LEEF Brands Comments on Federal Cannabis Rescheduling and Potential to Participate in Nationwide CBD Program

By The Northwire Desk — AI Analysis Dec 18, 2025 · 19:32 LEEF · 0.265 Leef Brands Inc.
LEEF · Price

Executive Summary

  • The U.S. President issued an executive order reclassifying cannabis from Schedule I to Schedule III under the Controlled Substances Act.
  • Re‑scheduling eliminates the 280E tax burden for LEEF Brands, which is expected to improve cash flow and lower cost of capital.
  • LEEF highlights additional strategic opportunities tied to emerging federal initiatives on hemp‑derived cannabinoids and potential Medicare coverage for CBD products.

Key Details

  • Executive Order: Cannabis moved from Schedule I to Schedule III, removing the most restrictive federal classification.
  • Tax Impact: Removal of 280E tax provision anticipated to materially improve LEEF’s cash flow and enable reinvestment in facilities and growth initiatives.
  • Capital Access: CFO Kevin Wilson notes that clearer regulation should broaden institutional investor participation, increase lender options, and reduce overall cost of capital for the cannabis sector.
  • Growth Outlook: Improved regulatory environment expected to provide “meaningful opportunities” to fund expansion, infrastructure upgrades, and scaling of operations.
  • Hemp‑Derived Cannabinoid Monitoring: LEEF is tracking federal developments on hemp‑derived cannabinoids and a CMS pilot program that could allow Medicare patients access to CBD products as early as 2026.
  • Strategic Assets: The company holds a dormant 100‑acre hemp permit at Salisbury Canyon Ranch and operates a high‑purity extraction platform, offering optionality as hemp regulations evolve.

Notable Quotes

“Cannabis rescheduling is a meaningful and long‑awaited step forward for patients, research, and operators,” – Micah Anderson, CEO, LEEF Brands.

“From a financial perspective, rescheduling has the potential to materially improve access to capital across the cannabis industry,” – Kevin Wilson, CFO, LEEF Brands.

Read the original news release →

More from Leef Brands Inc.

May 11, 2026 · 16:02

LEEF Brands Secures Expansion Capital as Margins Surge to Record Levels

Financings May 08, 2026 · 08:30

Strategic Regulatory Filing Confirms Execution of Federal Expansion Thesis

Regulatory May 06, 2026 · 16:02

LEEF Brands Validates Vertical Integration Model With Record Margins Despite Revenue Headwinds

Earnings Apr 28, 2026 · 08:30

LEEF Brands Closes Himalaya Acquisition; Q1 Earnings Awaited Amid Margin Expansion

Earnings Apr 16, 2026 · 08:30

Strategic Acquisition Adds Brand Value But Dilution Concerns Linger

M&A / Property Mar 25, 2026 · 16:02

N/A

Earnings